Home > Insider Trading > Filing (0001144204-15-010779)

Filing Details

Accession Number:: 0001144204-15-010779
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-18 21:52:09
Reporting Period:: 2014-01-29

Filing Date:: 2015-02-18
Accepted Time:: 2015-02-18 21:52:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001233	Sangamo Biosciences Inc	SGMO	Biological Products, (No Disgnostic Substances) (2836)	680359556

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1315082	Ra Capital Healthcare Fund Lp	C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116	No	No	No	Yes
1346824	Ra Capital Management, Llc	20 Park Plaza, Suite 1200 Boston MA 02116	No	No	No	Yes
1384859	Peter Kolchinsky	C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-04-03	195,126	$16.61	4,262,326	No	4	P	Direct
Common Stock	Acquisiton	2014-04-04	179,031	$15.38	4,441,357	No	4	P	Direct
Common Stock	Acquisiton	2014-04-07	33,667	$15.42	4,475,024	No	4	P	Direct
Common Stock	Acquisiton	2014-04-08	121,876	$15.49	4,596,900	No	4	P	Direct
Common Stock	Disposition	2014-04-09	69,856	$16.27	4,527,044	No	4	S	Direct
Common Stock	Acquisiton	2014-04-10	83,000	$14.91	4,610,044	No	4	P	Direct
Common Stock	Disposition	2014-04-10	3,403	$15.67	4,606,641	No	4	S	Direct
Common Stock	Acquisiton	2014-04-11	83,000	$14.48	4,689,641	No	4	P	Direct
Common Stock	Acquisiton	2014-04-11	33,992	$14.49	4,723,633	No	4	P	Direct
Common Stock	Disposition	2014-04-14	3,055	$14.78	4,720,578	No	4	S	Direct
Common Stock	Acquisiton	2014-04-15	1,079	$13.10	4,721,657	No	4	P	Direct
Common Stock	Acquisiton	2014-04-15	20,750	$13.16	4,742,407	No	4	P	Direct
Common Stock	Disposition	2014-04-16	21,829	$14.09	4,720,578	No	4	S	Direct
Common Stock	Acquisiton	2014-04-17	41,500	$14.02	4,762,078	No	4	P	Direct
Common Stock	Disposition	2014-04-22	39,591	$14.70	4,722,487	No	4	S	Direct
Common Stock	Disposition	2014-04-22	43,409	$14.86	4,679,078	No	4	S	Direct
Common Stock	Disposition	2014-04-22	166,000	$14.86	4,513,078	No	4	S	Direct
Common Stock	Disposition	2014-04-22	62,250	$14.88	4,450,828	No	4	S	Direct
Common Stock	Disposition	2014-04-22	41,500	$15.02	4,409,328	No	4	S	Direct
Common Stock	Acquisiton	2014-04-25	166,000	$13.63	4,575,328	No	4	P	Direct
Common Stock	Acquisiton	2014-04-28	74,844	$13.29	4,650,172	No	4	P	Direct
Common Stock	Acquisiton	2014-04-30	51,211	$13.29	4,701,383	No	4	P	Direct
Common Stock	Acquisiton	2014-04-30	73,289	$13.57	4,774,672	No	4	P	Direct
Common Stock	Acquisiton	2014-05-07	6,998	$11.71	4,781,670	No	4	P	Direct
Common Stock	Acquisiton	2014-05-07	40,566	$11.74	4,822,236	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	S	Direct
No	4	P	Direct
No	4	S	Direct
No	4	P	Direct
No	4	P	Direct
No	4	S	Direct
No	4	P	Direct
No	4	P	Direct
No	4	S	Direct
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Col 5 of Table I and the number of options reported in Col 9 of Table II reflect the number of shares or options, as applicable, beneficially owned by the Fund as of the time of the last transaction reported herein.